Moderna CEO Stephane Bancel discusses the efficacy of the firm's Covid-19 vaccine against future variants and plans to request U.S. clearance for use in young children, and progress on its flu vaccine. He speaks on "Bloomberg Surveillance."
Bloomberg
0 Comments